BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37091270)

  • 1. Ki67 and the apparent diffusion coefficient in postoperative prostate cancer with endocrine therapy.
    He J; Che B; Li P; Li W; Huang T; Chen P; Liu M; Li G; Zhong S; Tang K
    Front Surg; 2023; 10():1140883. PubMed ID: 37091270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
    Zhang Z; Xu H; Xue Y; Li J; Ye Q
    J Magn Reson Imaging; 2019 Feb; 49(2):556-564. PubMed ID: 30173421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ki67 in the prognosis of prostate cancer].
    Huang T; Liu JJ; Zhang JW; Zhu ZC; Wang T; Cai L; Chen ZQ
    Zhonghua Nan Ke Xue; 2019 Dec; 25(12):1088-1092. PubMed ID: 32251559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive model using prostate MRI findings can predict candidates for nerve sparing radical prostatectomy among low-intermediate risk prostate cancer patients.
    Song G; Ruan M; Wang H; Lin Z; Wang X; Li X; Li P; Wang Y; Zhou B; Hu X; Liu H; Wang H; Guo Y
    Transl Androl Urol; 2020 Apr; 9(2):437-444. PubMed ID: 32420149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of relationships between the final Gleason score, PI-RADS v2 score, ADC value, PSA level, and tumor diameter in patients that underwent radical prostatectomy due to prostate cancer.
    Gündoğdu E; Emekli E; Kebapçı M
    Radiol Med; 2020 Sep; 125(9):827-837. PubMed ID: 32266690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
    Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
    Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCE-MRI and DWI can differentiate benign from malignant prostate tumors when serum PSA is ≥10 ng/ml.
    Sun H; Du F; Liu Y; Li Q; Liu X; Wang T
    Front Oncol; 2022; 12():925186. PubMed ID: 36578948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.
    Thomas J; Gupta M; Grasso Y; Reddy CA; Heston WD; Zippe C; Dreicer R; Kupelian PA; Brainard J; Levin HS; Klein EA
    J Clin Oncol; 2002 Aug; 20(15):3213-8. PubMed ID: 12149293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
    Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
    Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy.
    Graefen M; Haese A; Pichlmeier U; Hammerer PG; Noldus J; Butz K; Erbersdobler A; Henke RP; Michl U; Fernandez S; Huland H
    J Urol; 2001 Mar; 165(3):857-63. PubMed ID: 11176486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.
    Naiki T; Okamura T; Nagata D; Mori Y; Kawai N; Ogawa K; Akita H; Hashimoto Y; Tozawa K; Kohri K
    Asian Pac J Cancer Prev; 2011; 12(4):909-13. PubMed ID: 21790224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10 ng/ml.
    Eminaga O; Hinkelammert R; Titze U; Abbas M; Eltze E; Bettendorf O; Semjonow A
    Urol Oncol; 2014 Jan; 32(1):32.e17-25. PubMed ID: 23434425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preoperative parameters, including percent of positive biopsy cores, in predicting pathological findings after radical prostatectomy].
    Inagaki T; Kohjimoto Y; Hagino K; Kuramoto T; Mori T; Kikkawa K; Iba A; Uekado Y; Shinka T
    Nihon Hinyokika Gakkai Zasshi; 2007 Mar; 98(3):565-72. PubMed ID: 17419367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification.
    Ploussard G; Masson-Lecomte A; Beauval JB; Ouzzane A; Bonniol R; Buge F; Fadli S; Rouprêt M; Rebillard X; Gaschignard N; Pfister C; Villers A; Soulié M; Salomon L;
    Urology; 2011 Sep; 78(3):607-13. PubMed ID: 21783233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of radical prostatectomy for prostate cancer from a single institution].
    Ishida R; Kobayashi H; Yoshida S; Ogawa M; Shiota T; Nishikimi T; Yamada H; Yokoi K
    Nihon Hinyokika Gakkai Zasshi; 2009 Sep; 100(6):615-24. PubMed ID: 19827538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Analysis of Biparametric MRI and Prostate-Specific Antigen Density: Role in the Prebiopsy Diagnosis of Gleason Score 7 or Greater Prostate Cancer.
    Lee SJ; Oh YT; Jung DC; Cho NH; Choi YD; Park SY
    AJR Am J Roentgenol; 2018 Sep; 211(3):W166-W172. PubMed ID: 30016148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.
    Yim JH; Kim CK; Kim JH
    J Magn Reson Imaging; 2018 Apr; 47(4):1072-1079. PubMed ID: 28901655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.